摘要:
The present invention relates to compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R 1 to R 5 , A, B, D and X are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
摘要:
The present invention pertains to a process for the preparation of functionalized trihalomethoxypyridines of formula (I) comprising reacting hydroxypyridines with thiophosgene in the presence of a base; reacting the obtained chlorothionoformiates with elemental chlorine and finally converting trichloromethoxy pyridines to trihalomethoxy pyridines using a fluoride source.
摘要:
Compounds represented by general formula (I), tautomers thereof, prodrugs of both, pharmaceutically acceptable salts of them, or solvates thereof exhibit an integrase-inhibiting activity. In said formula, X is hydroxyl or the like; Y is -C(=R?2)-R3-R4¿ (wherein R?2 and R3¿ are each oxygen or the like; and R4 is hydrogen or optionally substituted alkyl), optionally substituted heteroaryl, or the like; Z is hydrogen or the like; Z?1 and Z3¿ are each independently a single bond, alkylene, or the like; Z2 is a single bond, alkylene, -O-, or the like; R1 is optionally substituted aryl, optionally substituted heteroaryl, or the like; p is 0 to 2; and A is an optionally substituted aromatic heterocycle.
摘要:
Compounds of formula (I): in which: n represents an integer between 1 and 6 inclusive, X represents an oxygen atom or an NR6 group, Y represents a carbon atom or a nitrogen atom, Z represents a carbon atom or a nitrogen atom, R1 and R2 represent a hydrogen atom, or an alkyl or arylalkyl group, R3 and R4, represent a hydrogen atom or an alkyl group, R5 represents a hydrogen atom, or an optionally substituted alkyl, halogen, hydroxyl, alkoxy, cyano, nitro, acyl, alkoxycarbonyl, trihaloalkyl, trihaloalkoxy or amino group, R6 represents a hydrogen atom, or an alkyl or arylalkyl group, and Ra, Rb, Rc, Rd and Re are as defined in the description, Medicaments.
摘要:
The present invention relates to compounds that bind to chemokine receptors, and having the formula wherein each A, X, Y, R 1 , R 2 and R 3 are substituents. The present invention also relates to methods of using such compounds, such as in treating HIV infection and inflammatory conditions such as rheumatoid arthritis. Furthermore, the present invention relates to methods to elevate progenitor and stem cell counts, as well as methods to elevate white blood cell counts, using such compounds.